Chun-Ying Yeh-Huang
Director/Board Member bei TOT BIOPHARM INTERNATIONAL COMPANY LIMITED
Vermögen: 2 Mio $ am 31.03.2024
Profil
Chun-Ying Yeh-Huang is currently the Vice Chairman at TOT BIOPHARM International Co. Ltd.
since 2020 and the Director at Tot Biopharm Co. Ltd.
since 2023.
Previously, Ms. Yeh-Huang worked at TTY Biopharm Co. Ltd.
as the Executive VP-Oncology Science Business Development from 2011 to 2015.
Ms. Yeh-Huang completed their undergraduate degree at Taipei Medical University in 1982.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
10.01.2023 | 8 363 083 ( 1,08% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Chun-Ying Yeh-Huang
Unternehmen | Position | Beginn |
---|---|---|
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Director/Board Member | 19.01.2016 |
Tot Biopharm Co. Ltd.
Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China. | Director/Board Member | - |
Ehemalige bekannte Positionen von Chun-Ying Yeh-Huang
Unternehmen | Position | Ende |
---|---|---|
TTY BIOPHARM COMPANY LIMITED | Corporate Officer/Principal | 01.12.2015 |
Ausbildung von Chun-Ying Yeh-Huang
Taipei Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TTY BIOPHARM COMPANY LIMITED | Health Technology |
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Tot Biopharm Co. Ltd.
Tot Biopharm Co. Ltd. Pharmaceuticals: MajorHealth Technology Tot Biopharm Co. Ltd. engages in research and development, manufacturing and sales of new drugs. The company was founded on July 5, 2010 and is headquartered in Suzhou, China. | Health Technology |